Moody National Bank Trust Division’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.25M Buy
3,241
+16
+0.5% +$5.93K 0.1% 194
2026
Q1
$944K Buy
3,225
+290
+10% +$95.3K 0.09% 221
2025
Q4
$1.03M Sell
2,935
-1,542
-34% -$521K 0.1% 213
2025
Q3
$1.45M Buy
4,477
+306
+7% +$95.2K 0.12% 175
2025
Q2
$1.62M Sell
4,171
-382
-8% -$154K 0.15% 146
2025
Q1
$1.98M Sell
4,553
-141
-3% -$56.6K 0.21% 107
2024
Q4
$1.73M Sell
4,694
-101
-2% -$42.3K 0.18% 125
2024
Q3
$2.49M Buy
4,795
+631
+15% +$337K 0.27% 80
2024
Q2
$2.26M Buy
4,164
+121
+3% +$64K 0.18% 70
2024
Q1
$2.1M Buy
4,043
+56
+1% +$27.9K 0.17% 86
2023
Q4
$1.88M Sell
3,987
-3,057
-43% -$1.41M 0.15% 103
2023
Q3
$3.07M Buy
7,044
+990
+16% +$449K 0.2% 71
2023
Q2
$2.69M Buy
6,054
+115
+2% +$53.1K 0.18% 82
2023
Q1
$2.73M Sell
5,939
-9
-0.2% -$4.28K 0.23% 73
2022
Q4
$3.05M Sell
5,948
-11
-0.2% -$5.58K 0.27% 59
2022
Q3
$2.71M Hold
5,959
0.28% 62
2022
Q2
$2.88M Sell
5,959
-2,277
-28% -$1.13M 0.3% 56
2022
Q1
$4.05M Sell
8,236
-1,154
-12% -$527K 0.13% 51
2021
Q4
$4.35M Sell
9,390
-30,350
-76% -$12.8M 0.13% 59
2021
Q3
$14.8M Sell
39,740
-49
-0.1% -$18.6K 0.22% 53
2021
Q2
$15.2M Sell
39,789
-349
-0.9% -$133K 0.31% 50
2021
Q1
$14.4M Sell
40,138
-15
-0% -$4.82K 0.34% 54
2020
Q4
$12.9M Sell
40,153
-8
-0% -$2.46K 0.33% 58
2020
Q3
$10.8M Buy
40,161
+29
+0.1% +$7.8K 0.33% 64
2020
Q2
$10.6M Sell
40,132
-97
-0.2% -$25.9K 0.33% 62
2020
Q1
$9.13M Buy
40,229
+179
+0.4% +$48.8K 0.32% 58
2019
Q4
$12.1M Buy
40,050
+285
+0.7% +$78.4K 0.32% 52
2019
Q3
$9.55M Sell
39,765
-140
-0.4% -$38.4K 0.27% 62
2019
Q2
$11.3M Sell
39,905
-18,086
-31% -$4.94M 0.32% 52
2019
Q1
$16.6M Buy
57,991
+43
+0.1% +$12.4K 0.46% 29
2018
Q4
$15.2M Buy
57,948
+174
+0.3% +$47.8K 0.43% 29
2018
Q3
$15.8M Buy
57,774
+53,265
+1,181% +$13.8M 0.4% 31
2018
Q2
$1.07M Sell
4,509
-50
-1% -$11.6K 0.05% 64
2018
Q1
$1M Sell
4,559
-100
-2% -$23.5K 0.05% 70
2017
Q4
$1.05M Hold
4,659
0.05% 69
2017
Q3
$884K Sell
4,659
-1,300
-22% -$247K 0.04% 75
2017
Q2
$1.12M Hold
5,959
0.06% 72
2017
Q1
$986K Hold
5,959
0.05% 79
2016
Q4
$857K Hold
5,959
0.04% 94
2016
Q3
$747K Hold
5,959
0.04% 99
2016
Q2
$782K Hold
5,959
0.04% 98
2016
Q1
$828K Hold
5,959
0.05% 84
2015
Q4
$831K Hold
5,959
0.06% 76
2015
Q3
$835K Hold
5,959
0.06% 74
2015
Q2
$978K Hold
5,959
0.07% 68
2015
Q1
$920K Buy
5,959
+102
+2% +$14.5K 0.07% 71
2014
Q4
$736K Sell
5,857
-50
-0.8% -$6.18K 0.05% 112
2014
Q3
$706K Sell
5,907
-48
-0.8% -$5.51K 0.05% 101
2014
Q2
$641K Hold
5,955
0.04% 127
2014
Q1
$593K Hold
5,955
0.04% 127
2013
Q4
$550K Sell
5,955
-35
-0.6% -$3.11K 0.04% 137
2013
Q3
$501K Sell
5,990
-440
-7% -$37.7K 0.04% 140
2013
Q2
$526K Buy
+6,430
New +$481K 0.04% 126

Other funds holding ELV

Moody National Bank Trust Division's ELV Position: Q2 2026 in Review

Moody National Bank Trust Division increased its Elevance Health (ELV) stake by 0.5% in Q2 2026, buying an estimated $5.93K and bringing the position to 3,241 shares worth $1.25M. The position accounts for 0.1% of the portfolio, ranked #194.

Moody National Bank Trust Division first reported a position in ELV in Q2 2013 and has held it in 53 quarters since. The position peaked at $16.6M in Q1 2019. 660 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Moody National Bank Trust Division held 3,241 shares of Elevance Health worth $1.25M as of Q2 2026.
  • Moody National Bank Trust Division bought 16 Elevance Health shares in Q2 2026, an estimated $5.93K.
  • Elevance Health made up 0.1% of Moody National Bank Trust Division's portfolio in Q2 2026, its #194 holding.
  • Moody National Bank Trust Division first reported a position in Elevance Health in Q2 2013 and has held it in 53 quarters since.
  • Moody National Bank Trust Division's Elevance Health position peaked at $16.6M in Q1 2019.
  • 660 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Moody National Bank Trust Division's 13F filing for Q2 2026, filed 7 Jul 2026.